Dr Brendan Gerard Fennessy, MD | |
43 Whiting Hill Rd, Brewer, ME 04412-1005 | |
(207) 973-5000 | |
(207) 973-5042 |
Full Name | Dr Brendan Gerard Fennessy |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 43 Whiting Hill Rd, Brewer, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1851733075 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | MD20186 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Brendan Gerard Fennessy, MD 885 Union St, Ste 145, Bangor, ME 04401-3083 Ph: (207) 973-9595 | Dr Brendan Gerard Fennessy, MD 43 Whiting Hill Rd, Brewer, ME 04412-1005 Ph: (207) 973-5000 |
News Archive
The marathon quest to hold 28 health education events in 28 days earns a team of student pharmacists, physicians, nurses and therapists a national award.
A study published in the Aug. 4, 2010 issue of the Journal of Neuroscience introduces an enzyme that could pack a big punch in the battle against chronic pain. Its name is prostatic acid phosphatase or PAP for short. According to researchers at the University of North Carolina at Chapel Hill, PAP blocks pain in animal models by siphoning off a molecule called PIP2—a critical component of the chemical cascade behind chronic pain.
A study by University of Alabama at Birmingham researchers published April 1, 2013, in the journal Pediatrics showed that increasing numbers of premature and other low birth weight infants are the leading cause for the leveling off of infant mortality and neonatal mortality rates in the United States.
A robotic system can safely assist interventional cardiologists in performing percutaneous coronary interventions (PCI) while significantly reducing the physician's exposure to radiation and improving precision and control, according to results of the PRECISE study (CorPath Percutaneous Robotically-Enhance Coronary Intervention Study), presented today as a late-breaking clinical trial at the SCAI 2012 Scientific Sessions.
Parents and caregivers have traditionally relied on cribs, playpens and bassinets to protect children while they sleep. The massive crib recalls followed by the announcement in December 2010 by the United States Consumer Product Safety Commission to ban drop-side cribs have caused many families to question the safety of these products.
› Verified 1 days ago